ResearcherUniversity of Rome Tor VergataNo recent work listed

Laura Adesso

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5091435529. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper

Papers 1

Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. Co-author DOI 10.1038/onc.2012.306 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gianfranco Delle Fave · 1 shared paper, 2013 · strength 0.04
- Paper Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. DOI 10.1038/onc.2012.306 ↗
Claudio Sette · 1 shared paper, 2013 · strength 0.04
- Paper Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. DOI 10.1038/onc.2012.306 ↗
Sara Calabretta · 1 shared paper, 2013 · strength 0.04
- Paper Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. DOI 10.1038/onc.2012.306 ↗
Gabriele Capurso · 1 shared paper, 2013 · strength 0.04
- Paper Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. DOI 10.1038/onc.2012.306 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.